Angela Chu
Profile
Angela Chu was the Head of Engineering, Research & Development at Devax, Inc. She obtained undergraduate degrees from both Georgia Institute of Technology and the University of California, Berkeley.
Former positions of Angela Chu
Companies | Position | End |
---|---|---|
Devax, Inc.
Devax, Inc. Medical SpecialtiesHealth Technology Devax, Inc. is a private, emerging medical device company developing a proprietary bifurcated stent system that is intended to provide a clinical solution to treat atherosclerotic disease in coronary bifurcations and left main coronary arteries. Coronary artery disease continues to be the number one cause of death in the United States and Europe. The Company believes there is significant potential for its unique stent system to serve as a platform technology to address and provide tailored care for bifurcations wherever they occur including those found in carotid and peripheral vascular disease. Devax is headquartered in Lake Forest, California. | Chief Tech/Sci/R&D Officer | 2011-08-15 |
Training of Angela Chu
Georgia Institute of Technology | Undergraduate Degree |
University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Linked companies
Private companies | 1 |
---|---|
Devax, Inc.
Devax, Inc. Medical SpecialtiesHealth Technology Devax, Inc. is a private, emerging medical device company developing a proprietary bifurcated stent system that is intended to provide a clinical solution to treat atherosclerotic disease in coronary bifurcations and left main coronary arteries. Coronary artery disease continues to be the number one cause of death in the United States and Europe. The Company believes there is significant potential for its unique stent system to serve as a platform technology to address and provide tailored care for bifurcations wherever they occur including those found in carotid and peripheral vascular disease. Devax is headquartered in Lake Forest, California. | Health Technology |
- Stock Market
- Insiders
- Angela Chu